LiGalli revolutionizes women’s health by developing individual and adjustable drug delivery and diagnostics instead of one-size-fits-all.
The unique feature of the LiGalli innovative medical products is the combination of device-drug-diagnostic-electronic technology allowing customized solutions for the individual woman.
LiGalli is a Joint Venture initiative by Medimetrics / Philips and key pharmaceutical experts formerly employed by Organon.
“The near future of health care will be revolutionized by two important critical factors, technology and consumerism “
In: “The creative destruction of medicine” ( Eric Topol)